When to consider GLP-1 microdosing Based on current clinical practice patterns, practitioners are most commonly recommending GLP-1 microdosing in these scenarios: Partial responders: Patients on standard therapy who have improved but still experience breakthrough flares, residual inflammation, or persistent symptoms
Slower Digestion: They delay stomach emptying, helping you feel full for longer periods after meals
Obesity / chronic weight management is the fastest growing segment, driven by the escalation of world obesity and the growing body of evidence for the utility of GLP-1 therapies in weight loss
discuss with a clinician before changing therapy Spironolactone and some antipsychotics : may also affect sexual function Psychological factors including depression, anxiety, and diabetes-related distress can significantly impact sexual function
Our licensed medical providers offer personalized coaching and a structured weight loss program tailored to your needs